Screener
AptarGroup ATR Pharma — Net Sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by AptarGroup in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The source filing: AptarGroup’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 11:22 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000896622-26-000092
FAQ
- What is AptarGroup's pharma — net sales?
- AptarGroup (ATR) reported pharma — net sales of $438.91M in Q1 2026.
- How has AptarGroup's pharma — net sales changed year-over-year?
- AptarGroup's pharma — net sales increased by 7.1% year-over-year, from $409.7M to $438.91M.
- What does pharma — net sales mean?
- Represents the total revenue generated from the sale of dispensing systems to pharmaceutical and healthcare clients, net of returns and allowances. This is the primary indicator of market demand for the segment's specialized packaging products.
Ask your AI about AptarGroup's pharma — net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude